Background. In a variety of non-Hodgkin lymphomas, a correlation between soluble interleukin-2 receptor levels (sIL-2R) and clinical stage is demonstrable. In mycosis fungoides (MF), two findings raise the question as to a similar correlation: (1) a proportion of tumor cells express IL-2 receptor an
โฆ LIBER โฆ
Serum levels of soluble interleukin-2 receptor in Hodgkin disease. Relationship with clinical stage, tumor burden, and treatment outcome
โ Scribed by Achille Ambrosetti; Gianpaolo Nadali; Fabrizio Vinante; Stefano Carlini; Dino Veneri; Giuseppe Todeschini; Lorella Morosato; Donata de Sabata; Marco Chilosi; Enrico Maggi; Paola Parronchi; Sergio Romagnani; Gianpietro Semenzato; Giuseppe Perona; Giovanni Pizzolo
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 538 KB
- Volume
- 72
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Soluble interleukin-2 receptor serum lev
โ
Rolf-Markus Szeimies; Franziska Rueff; Peter Kaudewitz
๐
Article
๐
1992
๐
John Wiley and Sons
๐
English
โ 376 KB
๐ 2 views
Elevated serum levels of soluble interle
โ
Wilhelm H. Schmitt; Christoph Heesen; Elena Csernok; Annegret Rautmann; Wolfgang
๐
Article
๐
1992
๐
John Wiley and Sons
๐
English
โ 770 KB
To investigate whether soluble interleukin-2 receptor (sIL-~R), a marker of T cell activation, could be a useful marker of disease activity in Wegener's granulomatosis (WG). Methods. Soluble IL-2R levels were determined by enzyme-linked immunosorbent assay. WG disease activity in 102 patients was a
Detection of soluble interleukin-2 recep
โ
Roberto Stasi; Pier Luigi Zinzani; Piero Galieni; Vito Michele Lauta; Eugenio Da
๐
Article
๐
1994
๐
John Wiley and Sons
๐
English
โ 875 KB